Author:
Lin Jiexiang,Yang Zesong,Ye Liefu,Hong Yun,Cai Wanghai,Pan Honghong,Fu Haishou,Wu Jinfeng
Abstract
AbstractThis study aimed to analyze the infection risk factors for transurethral resection of the prostate (TURP) and establish predictive models to help make personalized treatment plans. Our study was designed one-center and retrospectively enrolled 1169 benign prostatic hyperplasia (BPH) patients. Risk factors were explored for postoperative infection. A TURP-postoperative infection (TURP-PI) model with infection prediction values was created. The improved-TURP-PI (I-TURP-PI) model, including extra new factors (pathogens species), was also built to see whether it could optimize the prediction abilities. At last, we developed a nomogram for better clinical application. Operation time, preoperative indwelling urinary catheter (PIUC), and positive preoperative urine culture were independent risk factors (all P < 0.05). Interestingly, pathogens species in pre-surgery urine (PEnterococcus faecium = 0.014, PPseudomonas aeruginosa = 0.086) were also independent risk factors. Patients with positive Enterococcus faecium (37.50%) were most likely to have postoperative infection. We built two models with AUCTURP-PI = 0.709 (95% CI 0.656–0.763) and AUCI-TURP-PI = 0.705 (95% CI 0.650–0.760). The nomogram could help improve the prediction ability. To our knowledge, our study is the first to use pathogen species in urine before surgery as risk factors for infection prediction after TURP. TURP-PI and I-TURP-PI models have essential roles in predicting patients' postoperative infections and in better postoperative antibiotic decision-making.
Funder
Natural Science Foundation of Fujian Province
Publisher
Springer Science and Business Media LLC
Reference32 articles.
1. Dornbier, R., Pahouja, G., Branch, J. & McVary, K. T. The New American Urological Association benign prostatic hyperplasia clinical guidelines: 2019 update. Curr. Urol. Rep. 21, 32 (2020).
2. Zhu, C. et al. Epidemiological trends of urinary tract infections, urolithiasis and benign prostatic hyperplasia in 203 countries and territories from 1990 to 2019. Mil. Med. Res. 8, 64 (2021).
3. Lerner, L. B. et al. Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA GUIDELINE PART II-surgical evaluation and treatment. J. Urol. 206, 818–826 (2021).
4. Rassweiler, J., Teber, D., Kuntz, R. & Hofmann, R. Complications of transurethral resection of the prostate (TURP)—Incidence, management, and prevention. Eur. Urol. 50, 969–979 (2006) (discussion 980).
5. Sun, F., Sun, X., Shi, Q. & Zhai, Y. Transurethral procedures in the treatment of benign prostatic hyperplasia: A systematic review and meta-analysis of effectiveness and complications. Medicine 97, e13360 (2018).
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献